Spillover effects of benefit expansions and carve-outs on psychotropic medication use and costs

Inquiry

Volumn 42, Issue 1, 2005, Pages 86-97

  Zuvekas, Samuel H ^a   Rupp, Agnes E ^b   Norquist, Grayson S ^c  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^b Health Economics Research   (United States)

^c UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; ARTICLE; DRUG COST; DRUG USE; FEMALE; HEALTH CARE COST; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAL SPECIALIST; MENTAL HEALTH; MULTIVARIATE ANALYSIS; PRESCRIPTION; PSYCHOSIS; SUBSTANCE ABUSE; BEHAVIORAL MEDICINE; COMPARATIVE STUDY; DISEASE MANAGEMENT; DRUG UTILIZATION; ECONOMICS; HEALTH INSURANCE; HEALTH SERVICES RESEARCH; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; RESIDENTIAL CARE;

ADULT; BEHAVIORAL MEDICINE; CATCHMENT AREA (HEALTH); DISEASE MANAGEMENT; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; ORGANIZATIONAL CASE STUDIES; PSYCHOTROPIC DRUGS;

EID: 22444431898     PISSN: 00469580     EISSN: None     Source Type: Journal    
DOI: 10.5034/inquiryjrnl_42.1.86     Document Type: Article

References (18)

1. Ai, C., and E.C. Norton. 2003. Interaction Terms in Logit and Probit Models. Economics Letters 80(1): 123-129.
2. Coffey, R.M., T. Mark, E. King, et al. 2001. National Estimates of Expenditures for Substance Abuse Treatment, 1997. SAMHSA Publication No. SMA-01-3511. Rockville, Md.: Center for Substance Abuse Treatment and Center for Mental Health Services, Substance Abuse and Mental Health Services Administration.
3. Congressional Budget Office (CBO). 1996. CBO's Estimates of the Impact on Employers of the Mental Health Parity Amendment in H.R. 3103. CBO memo, May 13.
4. -. 2001. Congressional Budget Office Cost Estimate: S.543 Mental Health Equitable Treatment Act of 2001. CBO memo, Aug. 22.
5. Duan, N. 1983. Smearing Estimate: A Nonparametric Retransformation Method. Journal of the American Statistical Association 78:605-610.
6. Goldman, W., J. McCulloch, B. Cuffel, and D. Kozma. 1999. More Evidence For the Insurability of Managed Behavioral Health Care. Health Affairs (September/October): 172-181.
7. Huskamp, H. 2003. Managing the Cost of Psychotropic Drugs. Health Affairs 22(5): 84-96.
8. Keeler, E.B., W.G. Manning, and K.J. Wells. 1988. The Demand for Episodes of Mental Health Services. Journal of Health Economics 7(4): 369-392.
9. Liang, K-Y., and S.L. Zeger. 1986. Longitudinal Data Analysis Using Generalized Linear Models. Biometrika 73(1): 13-22.
10. Ma, C.T., and T.G. McGuire. 1998. Costs and Incentives in a Mental Health Carve-out. Health Affairs 17(2): 53-69.
11. Manning, W.G., and J. Mullahy. 2001. Estimating Log Models: To Transform or Not To Transform? Journal of Health Economics 20: 461-494.
12. Manning, W.G. 1998. The Logged Dependent Variable, Heteroskedasticity, and the Retransformation Problem. Journal of Health Economics 27: 283-295.
13. Mark, T.L., R.M. Coffey, E. King, et al. 2000. Spending on Mental Health and Substance Abuse Treatment, 1987-1997. Health Affairs 19(4): 108-120.
14. Newhouse, J. 1992. Medical Care Costs: How Much Welfare Loss? Journal of Economic Perspectives 6(3): 3-21.
15. Sturm, R., W. Goldman, and J. McCulloch. 1998. Mental Health and Substance Abuse Parity: A Case Study of the Ohio State Employees Program. Journal of Mental Health Policy and Economics 1(2): 129-134.
16. Wooldridge, J.L. 2002. Econometric Analysis of Cross Section and Panel Data. Cambridge, Mass: The MIT Press.
17. Zeger, S.L., and K.-Y. Liang. 1986. Longitudinal Data Analysis for Discrete and Continuous Outcomes. Biometrics 42: 121-130.
18. Zuvekas, S.H., D.A. Regier, D.S. Rae, A. Rupp, and W.E. Narrow. 2002. The Impacts of Mental Health Parity and Managed Care in One Large Employer Group. Health Affairs 21(3): 148-159.